170719 ⎘
Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
Sub-classes:COMPOUND-DIAGNOSTIC MARKER FOR UTERINE BODY CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF UTERINE BODY CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF UTERINE BODY CANCER
#2CYCLIC PEPTIDES FOR TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR AND MUTATIONS THEREOF FOR DRUG DELIVERY
#3SWITCHING PEPTIDE, IMMUNOASSAY DEVICE COMPRISING SAME, AND IMMUNOASSAY METHOD USING SAME
#4ENGINEERING OF MULTIFUNCTIONAL PEPTIDES FOR CONTROLLED DRUG DELIVERY
#5ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING SUICIDAL BEHAVIORS IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS
#6ANIMAL, FUNGAL AND MARINE SOURCES OF CGP AND INCREASED CGP CONCENTRATION FOR DISEASE MANAGEMENT AND FOR TREATMENT OF NON-NEUROLOGICAL AND/OR NEUROLOGICAL CONDITIONS
#7Multiplexed Detection Of Toxins Using Graphene-Based Aptasensors
#8PEPTIDE AND PEPTIDE-CONTAINING COMPOSITION
#9Immunoassay controls and the use thereof
#10Immunoassay controls and the use thereof
#11Assays for detecting modified compounds
#12Method of evaluating quality of dephosphorylation reagent and method of detecting target nucleic acid
#13Peptoid compound and manufacturing method thereof, oligomer, pharmaceutical composition, and kit
#14IGF-1 analysis, adjustment and disease management of non-neurological and/or neurological conditions
#15IMMUNOSIGNATURING: A PATH TO EARLY DIAGNOSIS AND HEALTH MONITORING
#16THIOLATED AROMATIC BLOCKING STRUCTURES FOR EAB BIOSENSORS
#17Peptoid compound, and derivative, salt, preparation method and use thereof
#18Immunoassay controls and the use thereof
#19Multiplexed detection of toxins using graphene-based aptasensors
#20Constructs targeting histone H3 peptide/MHC complexes and uses thereof
#21Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis
#22Assays for detecting modified compounds
#23D-enantiomeric peptides derived from D3 and use thereof
#24METHOD OF DETECTING AUTO-ANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS, A PEPTIDE AND ASSAY KIT
#25Method and kit for detecting glutathione
#26Anti-CK8 antibodies for use in the treatment of colorectal cancers
#27D-enantiomeric peptides derived from D3 and use thereof
#28Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and assay kit
#29Chemical and biochemical adducts as biomarkers for organophosphate exposure
#30Detection of polymyxins
#31METHOD FOR STRATIFYING A FEMALE SUBJECT FOR HORMONE REPLACEMENT THERAPY
#32Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma
#33METHODS OF DETERMINING LEVELS OF FREE AMINO ACIDS AND DIPEPTIDES AND DIAGNOSING ALZHEIMER'S DISEASE
#34Method for predicting the risk of getting cancer or diagnosing cancer in a subject
#35NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF
#36Non-invasive method for measuring proliferation and differentiation state of cells by using magnetic resonance spectroscopy, and cell proliferation and differentiation marker for magnetic spectroscopy used therefor
#37Assays for detecting modified compounds
#38Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#39Screening for neurotoxic amino acid associated with neurological disorders
#40Assays for detecting modified compounds
#41Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma
#42Chemical and biochemical adducts as biomarkers for organophosphate exposure
#43METHOD OF ANALYZING PROTEIN MICROSTRUCTURE AND STRUCTURE FOR THE SAME
#44Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#45Screening for neurotoxic amino acid associated with neurological disorders
#46Methods of determining levels of free amino acids and dipeptides and diagnosing Alzheimer's disease
#47Identification of the hepcidin binding site on ferroportin
#48Screening for neurotoxic amino acid associated with neurological disorders
#49Screening for neurotoxic amino acid associated with neurological disorders
#50Assay for anti-INGAP antibodies
#51Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#52Screening for neurotoxic amino acid associated with neurological disorders